Accession Number: | 0001562180-20-000061 |
Date: | 2020-01-02 |
Issuer: | HEALTH CATALYST, INC. (HCAT) |
Original Submission Date: |
LLEWELYN LINDA
C/O HEALTH CATALYST, INC.
3165 MILLROCK DRIVE, #400
SALT LAKE CITY, UT 84121
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-01-02 | A | 25,377 | a | $0.00 | 25,377 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | includes 377 shares purchased pursuant to the issuer's 2019 employee stock purchase plan on december 31, 2019, which transaction is considered exempt pursuant to rule 16b-3(c) promulgated under the securities exchange act of 1934. |
f2 | represents an award of restricted stock units ("rsus") granted pursuant to the issuer's 2019 stock option and incentive plan (the "2019 plan"). each rsu represents a contingent right to receive one share of the issuer's common stock. subject to the terms of the 2019 plan, 25% of the rsus will vest on december 1, 2020 and, thereafter, the remaining 75% of the rsus will vest in 12 equal quarterly installments |